Details

Autor(en) / Beteiligte

• Demircioglu, Fevzi
• Wang, Jun
• Candido, Juliana
• Costa, Ana S. H.
• Casado, Pedro
• de Luxan Delgado, Beatriz
• Reynolds, Louise E.
• Gomez-Escudero, Jesus
• Newport, Emma
• Rajeeve, Vinothini
• Baker, Ann-Marie
• Roy-Luzarraga, Marina
• Graham, Trevor A.
• Foster, Julie
• Wang, Yu
• Campbell, James J.
• Singh, Rajinder
• Zhang, Penglie
• Schall, Thomas J.
• Balkwill, Frances R.
• Sosabowski, Jane
• Cutillas, Pedro R.
• Frezza, Christian
• Sancho, Patricia
• Hodivala-Dilke, Kairbaan

Titel

Cancer associated fibroblast FAK regulates malignant cell metabolism

Ist Teil von

• Nature communications, 2020-03, Vol.11 (1), p.1290-1290, Article 1290

Ort / Verlag

London: Nature Publishing Group UK

Erscheinungsjahr

2020

Quelle

Free E-Journal (出版社公開部分のみ）

Beschreibungen/Notizen

• Emerging evidence suggests that cancer cell metabolism can be regulated by cancer-associated fibroblasts (CAFs), but the mechanisms are poorly defined. Here we show that CAFs regulate malignant cell metabolism through pathways under the control of FAK. In breast and pancreatic cancer patients we find that low FAK expression, specifically in the stromal compartment, predicts reduced overall survival. In mice, depletion of FAK in a subpopulation of CAFs regulates paracrine signals that increase malignant cell glycolysis and tumour growth. Proteomic and phosphoproteomic analysis in our mouse model identifies metabolic alterations which are reflected at the transcriptomic level in patients with low stromal FAK. Mechanistically we demonstrate that FAK-depletion in CAFs increases chemokine production, which via CCR1/CCR2 on cancer cells, activate protein kinase A, leading to enhanced malignant cell glycolysis. Our data uncover mechanisms whereby stromal fibroblasts regulate cancer cell metabolism independent of genetic mutations in cancer cells. Cancer associated fibroblasts (CAFs) have been suggested to regulate cancer cell metabolism, but the mechanisms are not completely elucidated. Here, the authors show that low FAK expression in stromal cells correlates with poor prognosis in breast and pancreatic cancer patients and that FAK-silencing in CAFs promotes tumourigenesis by the paracrine regulation of cancer cell metabolism.